Print Page | Close Window

American Pacific Reports Fiscal 2010 Third Quarter Results

LAS VEGAS, Aug 04, 2010 /PRNewswire via COMTEX/ -- American Pacific Corporation (Nasdaq: APFC) today reported financial results for its fiscal 2010 third quarter ended June 30, 2010.

We provide non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data.

FINANCIAL SUMMARY

Quarter Ended June 30, 2010 Compared to Quarter Ended June 30, 2009

  • Revenues increased $5.8 million, or 18%, to $37.2 million from $31.4 million.
  • Operating loss was $3.6 million compared to $3.7 million.
  • Adjusted EBITDA was $0.0 million compared to $0.6 million.
  • Net loss was $4.6 million compared to $3.6 million.
  • Diluted loss per share was $0.61 compared to $0.48.

Nine Months Ended June 30, 2010 Compared to Nine Months Ended June 30, 2009

  • Revenues decreased $2.8 million, or 2%, to $130.7 million from $133.5 million.
  • Operating income was $2.0 million compared to $6.0 million.
  • Adjusted EBITDA was $14.0 million compared to $18.5 million.
  • Net loss was $4.9 million compared to $1.4 million.
  • Diluted loss per share was $0.65 compared to $0.18.

CONSOLIDATED RESULTS OF OPERATIONS

Revenues - For our third quarter of the fiscal year ending September 30, 2010 ("Fiscal 2010"), revenues increased 18% to $37.2 million as compared to the third quarter of the fiscal year ended September 30, 2009 ("Fiscal 2009"), primarily reflecting revenue increases of 28% and 30% for our Fine Chemicals and Specialty Chemicals segments, respectively. For the Fiscal 2010 nine-month period, revenues decreased 2% to $130.7 million as compared to the Fiscal 2009 nine-month period, reflecting an increase of 23% for our Aerospace Equipment segment revenues, offset by decreases of 7% and 14% in our Fine Chemicals segment and Specialty Chemicals segment revenues, respectively.

See further discussion under Segment Highlights.

Cost of Revenuesand Gross Margins - For our Fiscal 2010 third quarter, cost of revenues was $28.9 million compared to $24.2 million for the prior fiscal year third quarter. The consolidated gross margin percentage was 22% and 23% for our Fiscal 2010 and Fiscal 2009 third quarters, respectively. For the Fiscal 2010 nine-month period, cost of revenues was $93.1 million compared to $94.3 million for the prior fiscal year nine-month period. The consolidated gross margin percentage was 29% for both the Fiscal 2010 and Fiscal 2009 nine-month periods.

One of the most significant factors that affects, and should continue to affect, the comparison of our consolidated gross margins from period to period is the change in revenue mix between our segments. The revenue contribution by each of our segments is indicated in the following table.

                                           Three            Nine

                                           Months          Months

                                            Ended           Ended

                                          June 30,        June 30,

                                       2010   2009   2010   2009

                                        ---    ---    ---    ---

 

    Fine Chemicals                       54%    50%    48%    51%

    Specialty Chemicals                  22%    20%    27%    31%

    Aerospace Equipment                  23%    29%    21%    16%

    Other Businesses                      1%     1%     4%     2%

      Total Revenues                    100%   100%   100%   100%

                                        ===    ===    ===    ===

 

 

 

In addition, consolidated gross margins for our Fiscal 2010 periods reflect:

  • Changes in Fine Chemicals segment gross margin percentage primarily related to increased process validation costs and variances in manufacturing efficiencies between reporting periods.
  • Improvements in Specialty Chemicals segment gross margins due to better absorption of manufacturing overhead.
  • A decline in Aerospace Equipment segment gross margin percentage primarily due to increases in the estimated costs to complete certain of its systems contracts and the effect on gross margins from late deliveries.

See further discussion of these factors under the heading Segment Highlights.

Operating Expenses - For our Fiscal 2010 third quarter, operating expenses increased $1.0 million to $11.9 million from $10.9 million for the prior fiscal year third quarter. For our Fiscal 2010 nine-month period, operating expenses increased $2.4 million to $35.7 million from $33.3 million for the prior fiscal year nine-month period. The increases in operating expenses are associated with our Fine Chemicals and Aerospace Equipment segments. See further discussion of these factors under the heading Segment Highlights.

RECENT EVENTS

In May 2010, our board of directors approved amendments to our U.S. defined benefit plans which effectively closed these plans to participation by any new employees. Retirement benefits for existing U.S. employees and retirees through June 30, 2010 are not affected by this change. Beginning July 1, 2010, new U.S. employees will participate solely in one of the Company's 401(k) plans.

In June 2010, we repurchased and cancelled $5.0 million in principal amount of our 9% Senior Notes for $4.9 million, which approximated our carrying value of the notes, net of deferred financing costs.

In July 2010, our Fine Chemicals segment successfully completed the renegotiation and extension of its collective bargaining agreement to June of 2013.

In July 2010, our Aerospace Equipment segment, AMPAC-ISP, finalized a two year contract with OHB-System AG of Bremen, Germany, to produce fourteen Propulsion Modules for the Full Operational Capability portion of the satellite-supported European navigation system program. The constellation of navigation satellites will provide GPS-type coverage for a wide variety of users throughout the world.

SEGMENT HIGHLIGHTS

Fine Chemicals Segment

Our Fine Chemicals segment reflects the operating results of our wholly-owned subsidiaries Ampac Fine Chemicals LLC and AMPAC Fine Chemicals Texas, LLC (collectively, "AFC").

Quarter Ended June 30, 2010 Compared to Quarter Ended June 30, 2009

  • Revenues were $20.0 million compared to revenuesof $15.6 million.
  • Operating loss was $2.5 million compared to $0.8 million.
  • Segment EBITDA was $0.7 million, or 4% of segment revenues, compared to Segment EBITDA of $2.5 million, or 16% of segment revenues.

Nine Months Ended June 30, 2010 Compared to Nine Months Ended June 30, 2009

  • Revenues were $63.1 million compared to revenuesof $67.8 million.
  • Operating loss was $0.7 million compared to $0.4 million.
  • Segment EBITDA was $9.0 million, or 14% of segment revenues, compared to Segment EBITDA of $9.3 million, also 14% of segment revenues.

The increase in Fine Chemicals segment revenues for the Fiscal 2010 third quarter compared to the prior fiscal year third quarter primarily reflects an increase in revenues from our development products. Development product revenues include revenues from research products, products which are not yet commercialized, and products which are commercial but for which we are not the current commercial producer. Typically, development product activities are the source for future core products.

The decrease in Fine Chemicals segment revenues for the Fiscal 2010 nine-month period reflects reductions in orders for our antiviral products, offset partially by increases in revenues from development products. The decline in segment revenues for the Fiscal 2010 nine-month period is consistent with our expectation that annual Fiscal 2010 revenues for this segment will decline in the range of 20% to 25% as compared to Fiscal 2009.

Operating income and Segment EBITDA for the Fiscal 2010 third quarter and nine-month period declined compared to the prior fiscal year periods. For the Fiscal 2010 third quarter, the gross margin percentage declined ten points. The primary reason for the reduction in the third quarter gross margin percentage is higher than anticipated costs associated with validating a process change for a core product. In addition, the third quarter experienced other general manufacturing inefficiencies. On a year-to-date basis, Fiscal 2010 gross margins improved two points. Manufacturing improvements from the first two quarters of Fiscal 2010 were substantially offset by the Fiscal 2010 third quarter performance. Fine Chemicals segment operating expenses increased approximately $0.5 million for the Fiscal 2010 third quarter as compared to the prior fiscal year third quarter. The increase is largely attributed to incremental costs associated with the successful three-year renewal of our collective bargaining agreement, as well as additional costs associated with our recently acquired facility in Texas. For the Fiscal 2010 nine-month period, as compared to the prior fiscal year nine-month period, operating expenses increased $0.8 million reflecting the above-mentioned third quarter increases and an increase in business development activities.

Specialty Chemicals Segment

Our Specialty Chemicals segment revenues include the operating results from our perchlorate, sodium azide and Halotron product lines, with our perchlorate product lines comprising 87% and 89% of Specialty Chemicals segment revenues in Fiscal 2010 and Fiscal 2009 nine-month periods, respectively.

Quarter Ended June 30, 2010 Compared to Quarter Ended June 30, 2009

  • Revenues increased to $8.2 million from $6.3 million.
  • Operating income was $2.8 million, or 34% of segment revenues, compared to $0.6 million, or 9% of segment revenues.
  • Segment EBITDA was $2.8 million, or 34% of segment revenues, compared to $0.9 million, or 14% of segment revenues.

Nine Months Ended June 30, 2010 Compared to Nine Months Ended June 30, 2009

  • Revenues decreased to $35.1 million from $40.9 million.
  • Operating income was $15.1 million, or 43% of segment revenues, compared to $16.5 million, or 40% of segment revenues.
  • Segment EBITDA was $15.7 million, or 45% of segment revenues, compared to $17.4 million, or 43% of segment revenues.

The variances in Specialty Chemicals segment revenues reflect the following factors:

  • A 42% increase in perchlorate volume and a 2% increase in the related average price per pound for the Fiscal 2010 third quarter compared to the prior fiscal year third quarter.
  • A 29% decrease in perchlorate volume offset by an 18% increase in the related average price per pound for the Fiscal 2010 nine-month period compared to the prior fiscal year nine-month period.
  • Sodium azide revenues for the Fiscal 2010 third quarter decreased $0.5 million compared to the prior fiscal year third quarter and, for the Fiscal 2010 nine-month period, were consistent with the prior fiscal year period.
  • Halotron revenues increased $0.3 million for both the Fiscal 2010 third quarter and nine-month period, each compared to the comparable Fiscal 2009 periods.

For the Fiscal 2010 third quarter, the increase in perchlorate volume as compared to the prior year third quarter, reflects a difference in timing of perchlorate sales between the quarterly periods within each fiscal year. The decrease in volume for the Fiscal 2010 nine-month period is consistent with our expectation that, for the full Fiscal 2010 year, perchlorate volume will be down approximately 50% compared to the prior fiscal year.

The increases in average prices per pound reflect two offsetting factors:

  • The average price per pound of Grade I ammonium perchlorate ("AP") increased approximately proportionate and inverse to the decrease in Grade I AP volume consistent with the contractual Grade I AP price-volume matrix and comparable catalog pricing.
  • This was offset, in part, by our other lower-priced perchlorate products, such as sodium perchlorate and potassium perchlorate, which accounted for a greater percentage of all perchlorate product volume in the Fiscal 2010 periods. This change in the mix of perchlorate product sales had a reducing effect on the overall average price per pound of all perchlorate products. This factor had a greater effect on the Fiscal 2010 third quarter than on the Fiscal 2010 nine-month period.

Tactical missile programs accounted for a significant portion of perchlorate revenues in the Fiscal 2010 third quarter. In addition to the Fiscal 2010 third quarter activity, perchlorate revenues for the Fiscal 2010 nine-month period include space related programs, primarily the Ares program. For the Fiscal 2009 nine-month period, the greatest contributor to segment revenues was product for the Space Shuttle Reusable Solid Rocket Motor ("RSRM") program.

Operating income as a percentage of segment revenues was substantially lower in both the Fiscal 2010 and 2009 third quarters, each as compared to the nine-month periods in the corresponding fiscal years. This quarterly decline in operating margin occurs because segment revenues do not occur evenly between the quarters as compared to general and administrative expenses, which tend to be more consistent from quarter to quarter. As a result, quarters with lower volume, as was the case with the Fiscal 2010 and 2009 third quarters, report lower operating margin percentages.

Operating income as a percentage of segment revenues improved three points for the Fiscal 2010 nine-month period as compared to the prior fiscal year nine-month period. This improvement reflects the absorption of manufacturing overhead to inventory which is currently being produced to support early fiscal 2011 orders.

Aerospace Equipment Segment

Our Aerospace Equipment segment reflects the operating results of our wholly-owned subsidiary Ampac-ISP Corp. and its wholly-owned subsidiaries.

Quarter Ended June 30, 2010 Compared to Quarter Ended June 30, 2009

  • Revenues decreased 5% to $8.6 million from $9.1 million.
  • Operating loss was $0.1 million compared to operating income of $0.4 million.
  • Segment EBITDA was $0.3 million compared to $0.8 million.

Nine Months Ended June 30, 2010 Compared to Nine Months Ended June 30, 2009

  • Revenues increased 23% to $27.1 million from $22.0 million.
  • Operating loss was $0.5 million compared to operating income of $1.6 million.
  • Segment EBITDA was $0.8 million compared to $2.6 million.

Aerospace Equipment segment revenues decreased 5% for the Fiscal 2010 third quarter compared to the prior year third quarter because quarterly Fiscal 2010 segment revenues are expected to be weighted more to the first two quarters of Fiscal 2010. This differs from quarterly Fiscal 2009 segment revenues which were weighted more to the last two quarters of Fiscal 2009. Aerospace Equipment segment revenues increased 23% for the Fiscal 2010 nine-month period as compared to the prior fiscal year nine-month period. Revenue growth for the Fiscal 2010 nine-month period was driven by revenues for in-space propulsion engines. We expect that Aerospace Equipment segment revenues for the full Fiscal 2010 year will grow by approximately 10% compared to the prior fiscal year.

Operating profit and Segment EBITDA declined as a percentage of segment revenues for both the Fiscal 2010 third quarter and nine-month period. The gross margin percentage declined by one point for the Fiscal 2010 third quarter and seven points for the Fiscal 2010 nine-month period. These declines are attributed primarily to increases in estimated costs to complete certain systems contracts, as well as the impact on contract margins that results from late deliveries. Aerospace Equipment segment operating expenses increased $1.5 million primarily as a result of additional management and organization structure which was added to support the segment's European growth strategy, as well as increases in research and development expenses in both the U.S. and Europe.

CAPITAL AND LIQUIDITY HIGHLIGHTS

Liquidity - As of June 30, 2010, we had cash balances of $32.2 million and no cash borrowings against our $20.0 million revolving credit line. In addition, we were in compliance with the various covenants contained in our credit agreements.

Operating Cash Flows -Operating activities provided cash of $23.0 million for the Fiscal 2010 nine-month period compared to $11.4 million for the prior fiscal year nine-month period, resulting in an increase of $11.6 million.

Significant components of the change in cash flow from operating activities include:

  • A decrease in cash provided by Adjusted EBITDA of $4.5 million.
  • An increase in cash provided by working capital accounts of $16.2 million, excluding the effects of interest and income taxes.
  • An increase in cash paid for interest of $0.2 million.
  • An increase in cash taxes refunded of $0.1 million.
  • An increase in cash used for environmental remediation of $0.5 million.
  • An increase in other sources of operating cash flow of $0.5 million.

The increase in cash provided by working capital accounts for the Fiscal 2010 nine-month period reflects timing, and in particular as of June 30, 2010, the lower business volume and associated working capital requirements. We consider these working capital changes to be routine and within the normal production cycle of our products. The production of most fine chemical products requires a length of time that exceeds one quarter. In addition, the timing of Aerospace Equipment segment revenues recognized under the percentage-of-completion method differs from the timing of the related billings to customers. Therefore, in any given quarter, accounts receivable, work-in-progress inventory or deferred revenues can increase or decrease significantly. We expect that our working capital may vary normally by as much as $10.0 million from quarter to quarter.

Investing Cash Flows - Capital expenditures increased by $1.1 million in the Fiscal 2010 nine-month period compared to the prior fiscal year nine-month period due to the timing of expenditures. In April 2010, our Fine Chemicals segment expanded its manufacturing capacity through the purchase of a fine chemical facility in La Porte, Texas at a total cost of approximately $1.2 million, including direct purchase costs. The purchase of this facility is accounted for as a capital expenditure and accounts for the increase in capital expenditures as compared to the prior fiscal year period. Remaining capital expenditures in both periods were primarily maintenance capital related.

Financing Cash Flows - In June 2010, we repurchased and cancelled $5.0 million in principal amount of our 9% Senior Notes for $4.9 million, which approximated our carrying value of the notes, net of deferred financing costs.

OUTLOOK

We are updating our guidance for Fiscal 2010. We expect consolidated revenues of approximately $170.0 million and Adjusted EBITDA to range from $23.0 million to $25.0 million. The low end of our Fiscal 2010 guidance for Adjusted EBITDA is computed by adding estimated amounts for depreciation and amortization of $16.0 million, interest expense of $11.0 million, share-based compensation expense of $1.0 million and income tax benefit of $2.0 to estimated net loss of $3.0 million. We are anticipating our capital expenditures, which do not include environmental remediation spending, for Fiscal 2010 to be approximately $14.0 million.

The changes in our guidance primarily reflect our updated expectation that Fine Chemicals segment revenues will decline by approximately 20% to 25% in Fiscal 2010 as compared to Fiscal 2009, and the corresponding effects on Adjusted EBITDA and net loss. The current reduction in our expectation for Fiscal 2010 Fine Chemicals segment revenues reflects lower than anticipated development product revenues and the movement of certain projects into the next fiscal year.

INVESTOR TELECONFERENCE

We invite you to participate in a teleconference with our executive management covering our Fiscal 2010 third quarter financial results. The investor teleconference will be held Wednesday August 4, 2010 at 1:30 p.m., Pacific Daylight Time. The teleconference will include a presentation by management followed by a question and answer session. The teleconference can be accessed by dialing 866-700-5192 between 1:15 and 1:30 p.m., Pacific Daylight Time. Please reference passcode #24996585. As is our customary practice, a live webcast of the teleconference is being provided by Thomson Reuters. A link to the webcast and the earnings release is available at our website at www.apfc.com, and will be available for replay until a few days before our next quarterly investor teleconference.

RISK FACTORS/FORWARD-LOOKING STATEMENTS

The unaudited financial results included in this release are preliminary. Statements contained in this earnings release that are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including without limitation the statement regarding one of the significant factors that will affect comparisons of our consolidated gross margins in the future, the statement regarding anticipated Fiscal 2010 Fine Chemicals segment revenues, the statement regarding the anticipated total volume of perchlorate products to be sold in Fiscal 2010, the statements regarding the timing and anticipated amount of Fiscal 2010 revenues for our Aerospace Equipment segment, statements regarding our working capital changes and future variations, and statements in the "Outlook" section of this earnings release. Words such as "expect", "should", "will", "may", "can" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our expectations will be achieved. Actual results may differ materially from future results or outcomes expressed or implied by forward-looking statements set forth in the release due to risks, uncertainties and other important factors inherent in our business. Factors that might cause actual results to differ include, but are not limited to, the following:

  • We depend on a limited number of customers for most of our sales in our Specialty Chemicals, Aerospace Equipment and Fine Chemicals segments and the loss of one or more of these customers could have a material adverse effect on our financial position, results of operations and cash flows.
  • The inherent limitations of our fixed-price or similar contracts may impact our profitability.
  • The numerous and often complex laws and regulations and regulatory oversight to which our operations and properties are subject, the cost of compliance, and the effect of any failure to comply could reduce our profitability and liquidity.
  • A significant portion of our business depends on contracts with the government or its prime contractors or subcontractors and these contracts are impacted by governmental priorities and are subject to potential fluctuations in funding or early termination, including for convenience, any of which could have a material adverse effect on our operating results, financial condition or cash flows.
  • We may be subject to potentially material costs and liabilities in connection with environmental or health matters.
  • Although we have established an environmental reserve for remediation activities in Henderson, Nevada, given the many uncertainties involved in assessing environmental liabilities, our environmental-related risks may from time to time exceed any related reserves.
  • For each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments, most production is conducted in a single facility and any significant disruption or delay at a particular facility could have a material adverse effect on our business, financial position and results of operations.
  • The release or explosion of dangerous materials used in our business could disrupt our operations and cause us to incur additional costs and liabilities.
  • Disruptions in the supply of key raw materials and difficulties in the supplier qualification process, as well as increases in prices of raw materials, could adversely impact our operations.
  • Each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments may be unable to comply with customer specifications and manufacturing instructions or may experience delays or other problems with existing or new products, which could result in increased costs, losses of sales and potential breach of customer contracts.
  • Successful commercialization of pharmaceutical products and product line extensions is very difficult and subject to many uncertainties. If a customer is not able to successfully commercialize its products for which AFC produces compounds or if a product is subsequently recalled, then the operating results of AFC may be negatively impacted.
  • A strike or other work stoppage, or the inability to renew collective bargaining agreements on favorable terms, could have a material adverse effect on the cost structure and operational capabilities of AFC.
  • The pharmaceutical fine chemicals industry is a capital-intensive industry and if AFC does not have sufficient financial resources to finance the necessary capital expenditures, its business and results of operations may be harmed.
  • We may be subject to potential liability claims for our products or services that could affect our earnings and financial condition and harm our reputation.
  • Technology innovations in the markets that we serve may create alternatives to our products and result in reduced sales.
  • We are subject to strong competition in certain industries in which we participate and therefore may not be able to compete successfully.
  • Due to the nature of our business, our sales levels may fluctuate causing our quarterly operating results to fluctuate.
  • The inherent volatility of the chemical industry affects our capacity utilization and causes fluctuations in our results of operations.
  • A loss of key personnel or highly skilled employees, or the inability to attract and retain such personnel, could disrupt our operations or impede our growth.
  • We may continue to expand our operations in part through acquisitions, which could divert management's attention and expose us to unanticipated liabilities and costs. We may experience difficulties integrating the acquired operations, and we may incur costs relating to acquisitions that are never consummated.
  • We have a substantial amount of debt, and the cost of servicing that debt could adversely affect our ability to take actions, our liquidity or our financial condition.
  • We are obligated to comply with various ongoing covenants in our debt, which could restrict our operations, and if we should fail to satisfy any of these covenants, the payment under our debt could be accelerated, which would negatively impact our liquidity.
  • Significantchanges in discount rates, rates of return on pension assets, mortality tables and other factors could affect our estimates of pension obligations, which in turn could affect future funding requirements and related costs and impact our future earnings.
  • Our shareholder rights plan, Restated Certificate of Incorporation, as amended, and Amended and Restated By-laws discourage unsolicited takeover proposals and could prevent stockholders from realizing a premium on their common stock.
  • Our proprietary and intellectual property rights may be violated, compromised, circumvented or invalidated, which could damage our operations.
  • Our common stock price may fluctuate substantially, and a stockholder's investment could decline in value.

Readers of this earnings release are referred to our Annual Report on Form 10-K for Fiscal 2009, our Quarterly Reports on Form 10-Q for the quarters ended December 31, 2009 and March 31, 2010 and our other filings with the Securities and Exchange Commission for further discussion of these and other factors that could affect our future results. The forward-looking statements contained in this earnings release are made as of the date hereof and we assume no obligation to update for actual results or to update the reasons why actual results could differ materially from those projected in the forward-looking statements, except as required by law. In addition, the operating results for the quarter and nine months ended June 30, 2010 and cash flows for the nine months ended June 30, 2010 are not necessarily indicative of the results that will be achieved for future periods.

ABOUT AMERICAN PACIFIC CORPORATION

American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at http://www.apfc.com/.

    AMERICAN PACIFIC CORPORATION

    Condensed Consolidated Statements of Operations

    (Unaudited, Dollars in Thousands, Except per Share Amounts)

 

                                   Three Months

                                       Ended          Nine Months Ended

                                     June 30,              June 30,

                                   2010       2009       2010       2009

                                    ---        ---        ---        ---

 

    Revenues                    $37,247    $31,490   $130,706   $133,554

    Cost of Revenues             28,920     24,227     93,054     94,260

                                 ------     ------     ------     ------

      Gross Profit                8,327      7,263     37,652     39,294

    Operating Expenses           11,946     10,915     35,697     33,295

                                 ------     ------     ------     ------

      Operating Income (Loss)    (3,619)    (3,652)     1,955      5,999

    Interest and Other Income

     (Expense), Net                (291)        28       (559)        70

    Interest Expense              2,671      2,683      8,102      8,061

                                  -----      -----      -----      -----

      Loss before Income Tax     (6,581)    (6,307)    (6,706)    (1,992)

    Income Tax Benefit           (2,008)    (2,752)    (1,809)      (627)

                                 ------     ------     ------       ----

      Net Loss                  $(4,573)   $(3,555)   $(4,897)   $(1,365)

                                =======    =======    =======    =======

 

 

    Loss per Share:

      Basic                      $(0.61)    $(0.48)    $(0.65)    $(0.18)

      Diluted                    $(0.61)    $(0.48)    $(0.65)    $(0.18)

 

    Weighted Average Shares

     Outstanding:

      Basic                   7,491,000  7,483,000  7,489,000  7,482,000

      Diluted                 7,491,000  7,483,000  7,489,000  7,482,000

 

 

 

 

 

 

    AMERICAN PACIFIC CORPORATION

    Condensed Consolidated Balance Sheets

    (Unaudited, Dollars in Thousands, Except per Share Amounts)

 

                                                                 September

                                                       June 30,      30,

                                                           2010        2009

                                                            ---         ---

    ASSETS

    Current Assets:

      Cash and Cash Equivalents                         $32,161     $21,681

      Accounts Receivable, Net                           30,833      44,028

      Inventories                                        35,825      36,356

      Prepaid Expenses and Other Assets                   1,917       1,811

      Income Taxes Receivable                             3,149       2,148

      Deferred Income Taxes                               6,139       6,317

                                                          -----       -----

        Total Current Assets                            110,024     112,341

    Property, Plant and Equipment, Net                  112,664     114,645

    Intangible Assets, Net                                1,865       3,553

    Goodwill                                              2,631       3,144

    Deferred Income Taxes                                21,049      21,121

    Other Assets                                          9,753      10,037

                                                          -----      ------

        TOTAL ASSETS                                   $257,986    $264,841

                                                       ========    ========

 

    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current Liabilities:

      Accounts Payable                                   $9,647      $7,444

      Accrued Liabilities                                 4,638       5,295

      Accrued Interest                                    3,938       1,650

      Employee Related Liabilities                        6,838       6,930

      Income Taxes Payable                                   48         189

      Deferred Revenues and Customer Deposits             7,305       6,911

      Current Portion of Environmental Remediation

       Reserves                                           2,091       2,522

      Current Portion of Long-Term Debt                      65         151

                                                            ---         ---

        Total Current Liabilities                        34,570      31,092

    Long-Term Debt                                      105,113     110,097

    Environmental Remediation Reserves                   23,071      24,168

    Pension Obligations                                  28,925      27,720

    Other Long-Term Liabilities                             233         667

                                                            ---         ---

        Total Liabilities                               191,912     193,744

                                                        -------     -------

    Commitments and Contingencies

    Shareholders' Equity

      Preferred Stock -$1.00 par value; 3,000,000

       authorized; none outstanding                           -           -

      Common Stock -$0.10 par value; 20,000,000 shares

       authorized,

        7,543,091 and 7,504,591 issued                      754         750

      Capital in Excess of Par Value                     72,965      72,322

      Retained Earnings                                   5,100       9,997

      Accumulated Other Comprehensive Loss              (12,745)    (11,972)

                                                        -------     -------

        Total Shareholders' Equity                       66,074      71,097

                                                         ------      ------

        TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY     $257,986    $264,841

                                                       ========    ========

 

 

 

 

    AMERICAN PACIFIC CORPORATION

    Condensed Consolidated Statements of Cash Flows

    (Unaudited, Dollars in Thousands)

 

                                                            Nine Months

                                                                Ended

                                                             June 30,

                                                            2010       2009

                                                             ---        ---

    Cash Flows from Operating Activities:

      Net Loss                                           $(4,897)   $(1,365)

      Adjustments to Reconcile Net Loss

        to Net Cash Provided by Operating Activities:

          Depreciation and amortization                   11,980     11,971

          Non-cash interest expense                          472        473

          Share-based compensation                           635        474

          Deferred income taxes                              136        (14)

          Loss on sale of assets                              12         52

          Changes in operating assets and liabilities:

            Accounts receivable, net                      12,917      2,284

            Inventories                                      711     (4,847)

            Prepaid expenses and other current assets       (127)     1,792

            Accounts payable                                 756     (2,780)

            Income taxes                                  (1,125)      (262)

            Accrued liabilities                             (624)    (1,034)

            Accrued interest                               2,288      2,475

            Employee related liabilities                    (305)    (1,298)

            Deferred revenues and customer deposits          539      3,567

            Environmental remediation reserves            (1,528)      (987)

            Pension obligations, net                       1,451        859

            Other                                           (280)        (8)

              Net Cash Provided by Operating Activities   23,011     11,352

                                                          ------     ------

 

    Cash Flows from Investing Activities:

      Capital expenditures                                (7,392)    (6,312)

      Acquisition of business, net of cash acquired            -     (6,725)

      Other investing activities                              10          -

                                                             ---        ---

              Net Cash Used by Investing Activities       (7,382)   (13,037)

                                                          ------    -------

 

    Cash Flows from Financing Activities:

      Payments of long-term debt                          (5,048)      (272)

      Issuances of common stock, net                          11         32

                                                             ---        ---

          Net Cash Used by Financing Activities           (5,037)      (240)

                                                          ------       ----

 

    Effect of Changes in Currency Exchange Rates on Cash    (112)         -

                                                            ----        ---

 

    Net Change in Cash and Cash Equivalents               10,480     (1,925)

    Cash and Cash Equivalents, Beginning of Period        21,681     26,893

    Cash and Cash Equivalents, End of Period             $32,161    $24,968

                                                         =======    =======

 

 

 

 

 

    AMERICAN PACIFIC CORPORATION

    Supplemental Data

    (Unaudited, Dollars in Thousands)

 

                                      Three Months       Nine Months

                                          Ended              Ended

                                       June 30,           June 30,

                                      2010      2009      2010       2009

                                       ---       ---       ---        ---

 

    Operating Segment Data:

 

    Revenues:

      Fine Chemicals               $19,951   $15,644   $63,128    $67,766

      Specialty Chemicals            8,168     6,299    35,057     40,940

      Aerospace Equipment            8,647     9,085    27,140     21,977

      Other Businesses                 481       462     5,381      2,871

                                       ---       ---     -----      -----

        Total Revenues             $37,247   $31,490  $130,706   $133,554

                                   =======   =======  ========   ========

 

    Segment Operating Income

     (Loss):

      Fine Chemicals               $(2,458)    $(752)    $(698)     $(370)

      Specialty Chemicals            2,796       552    15,140     16,481

      Aerospace Equipment             (120)      417      (457)     1,571

      Other Businesses                (286)     (215)     (234)       164

                                      ----      ----      ----        ---

        Total Segment Operating

         Income (Loss)                 (68)        2    13,751     17,846

    Corporate Expenses              (3,551)   (3,654)  (11,796)   (11,847)

    Operating Income (Loss)        $(3,619)  $(3,652)   $1,955     $5,999

                                   =======   =======    ======     ======

 

    Depreciation and Amortization:

      Fine Chemicals                $3,200     3,281    $9,722      9,625

      Specialty Chemicals               14       324       591        951

      Aerospace Equipment              424       378     1,239      1,032

      Other Businesses                   4         3        12          9

      Corporate                        162       115       416        354

                                       ---       ---       ---        ---

        Total Depreciation and

         Amortization               $3,804    $4,101   $11,980    $11,971

                                    ======    ======   =======    =======

 

    Segment EBITDA (a):

      Fine Chemicals                  $742    $2,529    $9,024     $9,255

      Specialty Chemicals            2,810       876    15,731     17,432

      Aerospace Equipment              304       795       782      2,603

      Other Businesses                (282)     (212)     (222)       173

                                      ----      ----      ----        ---

        Total Segment EBITDA         3,574     3,988    25,315     29,463

    Less: Corporate

     Expenses, Excluding

     Depreciation                   (3,389)   (3,539)  (11,380)   (11,493)

    Plus: Share-based

     Compensation                      146       169       635        474

    Plus: Interest and Other

     Income (Expense), Net            (291)       28      (559)        70

    Adjusted EBITDA (b)                $40      $646   $14,011    $18,514

                                       ===      ====   =======    =======

 

    Reconciliation of Net Loss to

     Adjusted EBITDA (b):

 

    Net Loss                       $(4,573)  $(3,555)  $(4,897)   $(1,365)

    Add Back:

      Income Tax Expense            (2,008)   (2,752)   (1,809)      (627)

      Interest Expense               2,671     2,683     8,102      8,061

      Depreciation and

       Amortization                  3,804     4,101    11,980     11,971

      Share-based

       Compensation                    146       169       635        474

                                       ---       ---       ---        ---

    Adjusted EBITDA                    $40      $646   $14,011    $18,514

                                       ===      ====   =======    =======

 

 

 

    (A) Segment EBITDA is defined as segment operating income (loss) plus

    depreciation and amortization.

 

    (B) Adjusted EBITDA is defined as net income (loss) before income tax

    expense (benefit), interest expense,

    depreciation and amortization, share-based compensation and

    environmental remediation charges (if any).

 

    Segment EBITDA and Adjusted EBITDA are not financial measures

    calculated in accordance with GAAP and

    should not be considered as an alternative to income (loss) from

    operations as performance measures.  Each

    EBITDA measure is presented solely as a supplemental disclosure

    because management believes that each is

    a useful performance measure that is widely used within the

    industries in which we operate. In addition,

    EBITDA measures are significant measurements for covenant compliance

    under our revolving credit facility.

    Each EBITDA measure is not calculated in the same manner by all

    companies and, accordingly, may not be an

    appropriate measure for comparison.

 

 

SOURCE American Pacific Corporation